Author Affiliation: Department of Internal Medicine 3, Medical University of Vienna, Vienna, Austria (firstname.lastname@example.org).
To the Editor: Dr Fried and colleagues1 reported the effects of oral silymarin in patients with chronic hepatitis C virus (HCV) infection who had not responded to standard antiviral treatment. Oral silymarin is used worldwide as a treatment for liver disorders, either by prescription or as a nutritional supplement. A controlled study showed a survival benefit in patients with cirrhosis,2 and other data indicated that the intravenous preparation is a potent antiviral agent against HCV.3
Ferenci P. Treatment With Silymarin for Hepatitis C Virus. JAMA. 2012;308(18):1856–1857. doi:10.1001/jama.2012.13741
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: